BioSpace News Archive

PTC Therapeutics, Inc. announced that on August 18, 2020 it approved non-statutory stock options to purchase an aggregate of 49,165 shares of its common stock and 14,175 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to five new employees.

Medifocus Inc. (TSXV-MFS) (“Medifocus” or the “Company”) today announced that Mr. Mirsad Jakubovic has resigned as Chief Financial Officer of the Company.

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2020 Third Quarter financial results on Monday August 24th, 2020, before markets open.

Enteral nutrition or enteral feeding is defined as delivery of proteins, minerals, and other essential nutritional products directly into the stomach of a patient with the help of tubes.

BioInvent International AB will issue its interim report for the second quarter 2020 on Thursday August 27 at 8.00 a.m. CEST, followed by an audiocast with teleconference at 5.30 p.m.

The demand within the global market for cardiac resynchronisation therapy systems has been rising at a skyrocketing pace, majorly due to advancements in the field of cardiology.

New analyses of the interim analysis data from the Phase 3 REGENERATE study describe the benefit of obeticholic acid (OCA) on noninvasive measures of liver fibrosis in NASH patients on treatment for at least 24 months Additional long-term data in PBC highlight the safety and durable efficacy of OCA through six years of open label treatment NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and